Israel Biotech Fund
Venture capitalRehovot · Seed–Series A · 4 people tracked
Also known as I.B.F. MANAGEMENT LTD.
Find your way into Israel Biotech Fund
638 people in our graph share verified history with the Israel Biotech Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Israel Biotech Fund invests in biotechnology and pharmaceutical companies based in or connected to Israel, operating across the development and growth stages. The fund focuses on building Israeli biotech enterprises with the objective of delivering capital appreciation to investors.
Source: firm website, verified Sep 15, 2026.
Team · 4 people
from public directories
What they invest in
from 17 of 19 portfolio companiesBiotech ×17Healthtech ×9Medical Devices ×7AI & Machine Learning ×5Deep Tech ×4Digital Health ×2Advanced Manufacturing ×1Longevity ×1
HQs:Israel×5United States×5
Investments · 19 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12017 · 22015 · 37 dated
Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.
AI & Machine LearningBiotechHealthtechHackensack, US
Ronnie Morris(Executive Officer, Director)inRonnie Morris, M.D.(Executive Officer, Director)inJames McGorry(Executive Officer)David Miller(Chief Financial Officer)inJoel Ackerman(Executive Officer, Director)inRob Brainin(Chief Executive Officer)in
Board seatDavid Sidransky· per SEC Form D · $14M raise · filed Mar 2015
Co-investorsBattery VenturesNew Enterprise Associates (NEA)
Galmed is a pharmaceutical company developing metabolic and inflammatory therapeutic drugs through discovery and clinical trial phases.
BiotechTel Aviv
Ran Oren(Director)Tali Gorfine(Executive Officer)Carol Brosgart(Director)Yohai Stenzler(Executive Officer)Liat Hayardeny(Executive Officer)Shmuel Nir(Director)
Board seatDavid Sidransky· per SEC Form D · $350K raise · filed Aug 2017
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Ety Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
Co-investorsClal Biotechnology IndustriesDeep InsightGandyr InvestmentsNew Era Capital Partners
AION Labs is a venture studio founded by pharmaceutical companies (AstraZeneca, Pfizer, Merck, Teva) alongside AWS and venture capital partners to build and scale companies applying AI and emerging technologies to drug discovery and development.
AI & Machine LearningBiotechDeep Tech
Dr. Yuval Cabily(Co-Founder & Managing Partner)Ido Zairi(Co-founder & Managing Partner)in
Co-investorsAmiti Ventures
Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies.
BiotechDeep TechHealthtechMedical Devices
Lana Volokh(Co-founder)Alex Tendler(Co-founder)Yevgeny Tendler(CSO)
Co-investorsPeregrine Ventures
Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall.
BiotechHealthtechMedical Devices
Avner Geva(CEO, Co-founder)inAvi Eftel(CTO, Co-founder)inRoger R. Dmochowski(CMO)Ken Berlin(Executive Chairman)in
Co-investorsTrendlines Group
Orgenesis provides decentralized manufacturing infrastructure for cell and gene therapies, enabling on-site processing of CGTs in regional centers through its POCare™ platform and OMPUL™ mobile processing units.
Advanced ManufacturingBiotechHealthtechMedical DevicesGermantown, US
Neil Reithinger(Executive Officer)inVered Caplan(Executive Officer, Director)inFerber Ferber(Executive Officer)Joseph Tenne(Executive Officer)inSarah Ferber(Executive Officer)
Board seatDavid Sidransky· per SEC Form D · $10M raise · filed Dec 2015
BiotechSan Diego, US
Jamie Sulley(Executive Officer, Director)Joanne Barsa(Executive Officer)
BoardFred Knoll(Director)David Sidrandky(Director)Patrick Ostronick(Director)
Board seatDavid Sidransky· per SEC Form D · $800K raise · filed Sep 2015
4C Biomed develops an immunological screening platform to identify drug targets for cancer immunotherapy development.
AI & Machine LearningBiotechDigital HealthHealthtechTel Aviv, IL
Anthony Angel(Chairman & Co-founder)Dr. Alan Barge(Chief Executive Officer & Co-founder)Dr. Eyal Greenberg(Chief Development Officer & Scientific Co-founder)Prof. Gal Markel(Chief Scientific Officer & Co-founder)Prof. Jacob Schachter(Chief Medical Officer & Co-founder)
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Biotech
Co-investorsaMoon
Biond Bio is a clinical-stage biotechnology company developing first-in-class antibody therapies for oncology and immune-mediated diseases, targeting immune evasion mechanisms and pathological pathways.
BiotechHealthtech
Co-investorsDeep Insight
Biosight was a pharmaceutical company that merged with Ayala Pharmaceuticals on October 19, 2023.
Biotech
Co-investorsTrendlines Group
Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications.
BiotechHealthtechLongevityMedical Devices
Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms.
BiotechDeep TechMedical Devices
Co-investorsPeregrine VenturesCancer Focus
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)inYanay Ofran(Director)inJudith Weiss Paltiel(PhD, VP Development)in
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalLeaps by BayerPeakBridge VC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AdvaxisExoprotherPharma2B
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 4
3 IPOs · 1 acquisitions · showing 3Champions OncologyNASDAQ: CSBRGalmed PharmaceuticalsNASDAQ: GLMDMediwoundNASDAQ: MDWD
Portfolio news
latest coverage across their companiesChampions Oncology · intellectia.ai · Jul 29, 2026
Orgenesis · finimize.com · Sep 6, 2025
Frequently asked questions
- How many investments has Israel Biotech Fund made?
- Israel Biotech Fund has 19 tracked investments, 4 of which have exited.
- What stage does Israel Biotech Fund invest at?
- Israel Biotech Fund invests at the Seed, Series A stages.
- What sectors does Israel Biotech Fund focus on?
- Israel Biotech Fund focuses on Biotech, Digital Health, Medical Devices.
- Where is Israel Biotech Fund located?
- Israel Biotech Fund is headquartered in Rehovot, IL.
- Does Israel Biotech Fund lead rounds?
- Israel Biotech Fund has led 3 of the 3 rounds where its role is on record.
- Who does Israel Biotech Fund co-invest with?
- Israel Biotech Fund most often shares deals with Deep Insight, Amiti Ventures, Khosla Ventures, among 11 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.